Cena / účtovná hodnotae spoločnosti Apollo Endosurgery Inc

Aká je hodnota metriky Cena / účtovná hodnotae spoločnosti Apollo Endosurgery Inc?

Hodnota metriky Cena / účtovná hodnotae spoločnosti Apollo Endosurgery Inc je 12.01

Aká je definícia metriky Cena / účtovná hodnotae?



Cena / učtovná hodnota (Price to book ratio) ukazateľ vyjadruje pomer medzi hodnotou spoločnosti a book value spoločnosti, čo je hodnota čistých aktív.

The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).

The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).

P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.

Cena / účtovná hodnotae spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Apollo Endosurgery Inc

Čomu sa venuje spoločnosť Apollo Endosurgery Inc?

Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.

Firmy s metrikou cena / účtovná hodnotae podobnou spoločnosti Apollo Endosurgery Inc



  • Hodnota metriky Cena / účtovná hodnotae spoločnosti IFB Industries je 11.94
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti INEO Tech je 11.95
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Foseco India je 11.95
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Atari SA je 11.96
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Aditya Birla Money je 11.98
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Manitou Gold je 12.01
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Apollo Endosurgery Inc je 12.01
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti UET United Electronic Technology AG je 12.01
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Vesuvius India je 12.01
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Norwest NL je 12.03
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Genesys International je 12.03
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Relx Plc je 12.04
  • Hodnota metriky Cena / účtovná hodnotae spoločnosti Qualys Inc je 12.05